Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F. Diamantogiannis
Pcn185 - Cost-Effectiveness of Nivolumab in Second-Line Treatment of Locally Advanced Unresectable or Metastatic Urothelial Carcinoma in Adults After Failure of Prior Platinum-Containing Therapy in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Vinflunine in Platinum-Pretreated Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Cancer
Cancer Research
Oncology
Pcn190 - Cost-Effectiveness of Nivolumab + Ipilimumab in First-Line Treatment of Advanced or Metastatic Renal Cell Carcinoma in the Netherlands
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pembrolizumab in the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: Clinical Trial Evidence and Experience
Therapeutic Advances in Urology
Urology
Pcn138 - Cost-Effectiveness Analysis of Pembrolizumab in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Cancer in England
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn178 - Cost-Effectiveness of Pembrolizumab as Second-Line Treatment for Patients With Advanced Urothelial Cancer in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn144 - Cost-Effectiveness of Cabozantinib for Patients With Advanced Renal Cell Carcinoma After Failure of Prior Therapy in South Korea
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn139 - Cost-Effectiveness Analysis of Pembrolizumab for Patients With Locally Advanced or Metastatic Urothelial Cancer Who Are Ineligible for Cisplatin-Containing Chemotherapy in England
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Safety and Effectiveness of Vinflunine in Patients With Metastatic Transitional Cell Carcinoma of the Urothelial Tract After Failure of One Platinum-Based Systemic Therapy in Clinical Practice
BMC Cancer
Cancer Research
Oncology
Genetics
Cost Effectiveness of Regorafenib as Second-Line Therapy for Patients With Advanced Hepatocellular Carcinoma
Cancer
Cancer Research
Oncology
